Welcome Back |Sign in | Register
Your Position: Home > Inhibitors/Agonists > Vc-MMAD

View History

Vc-MMAD
prev zoom next

Name:Vc-MMAD

  • Catalog No.:
  • BCM006398
  • Chem Name:
  • 4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-3-methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate
  • Synonym:
  • Vc-MMAD; Val-Cit-MMAD; Val-Cit-Monomethylauristatin D;
  • CAS No.:
  • 1401963-17-4
  • MDL No.:
  • MFCD26960950
  • Formula:
  • C70H104N12O14S
  • Molecular:
  • 1369.71176
  • Wish  | Compare  | Referral bonuses
SKU Specification Brand Prices Stock Quantity Cart
BCM006398-1MG 1mg, Purity:98% BCM $150 1 Add Cart
BCM006398-10MG 10mg, Purity:98% BCM $549 2 Add Cart
BCM006398-50MG 50mg, Purity:98% BCM $1780 2 Add Cart
For more quantities, please contact telephone:0755-85269922,Or send an email to:sales@biochemmall.com

Product Description

Attribute

Goods Tag

Related Products

 

Vc-MMAD is an antibody-conjugated drug (ADC), and Val-Cit acts as a linker and connects to microtubule inhibitor MMAD.

 

Brand: BCM

 

Boling Point: 1370.7±65.0 °C at 760 mmHg

 

Attribute
[Chem Name] 4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-3-methoxy-1-((S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)amino)propyl)pyrrolidin-1-yl)-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate
[Synonym] Vc-MMAD; Val-Cit-MMAD; Val-Cit-Monomethylauristatin D;
[CAS No.] 1401963-17-4
[MDL No.] MFCD26960950
[Formula] C70H104N12O14S
[Molecular] 1369.71176

Goods Tag

User Comment(Total0User Comment Num)

  • No comment
Total 0 records, divided into1 pages. First Prev Next Last
Username: Anonymous user
E-mail:
Rank:
Content:
Verification code: captcha